✦ LIBER ✦

Mitoxantrone and cytarabine versus daunorubicin and cytarabine in previously untreated patients with acute myeloid leukemia

✍ Scribed by Anders Wahlin; Per Hörnsten; Michael Hedenus; Claes Malm

Publisher: Springer
Year: 1991
Tongue: English
Weight: 355 KB
Volume: 28
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685827

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized study of mitoxantrone plus

A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute nonlymphocytic leukemia

✍ S. Pavlovsky; J. Gonzalez Llaven; M. A. Garcia Martinez; P. Sobrevilla; M. Eppin 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 444 KB

Arsenic trioxide and low-dose cytarabine

Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia

✍ Gail J. Roboz; Ellen K. Ritchie; Tania Curcio; Juliette Provenzano; Rebecca Carl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

## Abstract ## BACKGROUND. Acute myeloid leukemia (AML) carries a dismal prognosis in older patients. In this study, the authors evaluated the safety and efficacy of arsenic trioxide combined with low‐dose cytarabine in untreated patients aged ≥60 years with AML. ## METHODS. In a phase 1/2 desig

Improved outcome of patients with low- a

Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine : Results of a retrospective comparative study

✍ Thomas Prebet; Anne Etienne; Raynier Devillier; Emilie Romeo; Aude Charbonnier; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

Imatinib combined with mitoxantrone/etop

Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis

✍ Stefan Fruehauf; Julian Topaly; Eike C. Buss; Thomas Fischer; Oliver G. Ottmann; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

A randomized trial of continuous infusio

A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia

✍ Yener Koc; Basak Oyan; Ayse Kars; Gulten Tekuzman; Hande Canpinar; Emin Kansu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

## Abstract Mitoxantrone (MTZ) has been shown to be effective in the treatment of newly diagnosed acute myeloblastic leukemia (AML). The objective of this randomized study was to evaluate the impact of mode of administration of MTZ on the response and recurrence rates in newly diagnosed patients wi

High-dose liposomal daunorubicin and hig

High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia

✍ Jorge Cortes; Elihu Estey; Susan O'Brien; Francis Giles; Yu Shen; Charles Koller 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Background: Liposomal encapsulation of daunorubicin (daunoxome, dnx; nexstar pharmaceutical, boulder, co) changes the pharmacology profile to increase delivery to tumor sites and decrease toxicity. the authors investigated the effect of daunorubicin in combination with ara-c in patients with ref